Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Certain vitamins and their derivatives can help hair grow longer by activating specific growth signals.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

More research is needed to find the best long-term treatments for Alopecia Areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

Recent advances in hair loss treatments show significant progress.

Finasteride may help some women with hair loss, but better options exist.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Topical finasteride helps regrow hair and reduce hair loss in men and women.